What is the timeline for the closing of the extended tranches and when will the funds be available to the company?

Timeline & Fund Availability

The TSX Venture Exchange has approved an extension of the private‑placement closing to September 1 2025 for the additional tranches of Acceleware’s non‑brokered placement. Once the closing occurs on—or very near—that date, the proceeds from those tranches will be transferred to the company’s accounts immediately, i.e., the funds become available to Acceleware on the closing date (September 1 2025) when the securities are issued and the cash is deposited.

Trading Implications

- Liquidity boost: The infusion of capital (expected to be several million dollars) will strengthen the balance sheet, fund ongoing RF‑power‑to‑heat projects, and support the company’s expansion into critical‑minerals and carbon‑capture applications. This improves the firm’s near‑term solvency metrics, which may lift sentiment and reduce the risk premium priced into the stock.

- Price action: Expect a modest uptick in share price leading up to the September 1 deadline as investors price in the anticipated cash infusion. Look for a bullish short‑term bias on the daily chart, especially if the stock trades in a tight range; a breakout above recent resistance (e.g., the $1.20‑$1.25 level) could be a cue for a quick trade, with a stop just below the prior low (≈ $1.10).

- Risk management: The financing is non‑dilutive in the short term because the units are priced at a discount to the current market, which may cause short‑term dilution concerns. However, the funds are earmarked for growth projects, so the longer‑term upside outweighs the dilution effect. Traders can consider a buy‑on‑breakout strategy with a 2‑4 % target, while monitoring any news on the placement subscription rates. If the closing is delayed beyond September 1, the price could be pressured, so a stop‑loss at the pre‑announcement low is advisable.